Verdant Bio CEO Featured in The Meridian Review on the Future of Personalized Healthcare

Starproof Reputation · For immediate release · Contact: press@starproofpr.com

September 14, 2026 — Verdant Bio chief executive Dr. Lena Marsh joins The Meridian Review this week to set out her vision for personalized healthcare, in a feature secured and prepared by Starproof Reputation.

The interview covers Verdant Bio's diagnostic platform, now used in over 300 clinics, and Marsh's argument that prevention — not treatment — should anchor the next decade of health spending. The feature includes trial data reviewed by the company's clinical board and commentary from two independent physicians.

"Healthcare knows more about each patient than ever before, yet most care pathways still treat everyone the same," said Marsh. "Our job is to turn that data into decisions a family doctor can act on in a ten-minute appointment."

Starproof Reputation managed the placement end to end: story development, journalist briefing, interview preparation, and launch-day distribution that carried the feature into three additional health and business outlets.

About Verdant Bio

Verdant Bio builds diagnostic tools that help clinicians personalize treatment plans. Backed by Horizon Ventures, the company serves more than 300 clinics and processes over two million tests a year.

About Starproof Reputation

Starproof Reputation is a full-service PR & communications agency helping brands stay seen, heard, and trusted. Media contact: press@starproofpr.com.